Patents by Inventor Roderich Süssmuth

Roderich Süssmuth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090298904
    Abstract: The disclosure relates to a compound of the formula (I) wherein m and n are independently of one another 0, 1 or 2, obtainable from Actinomadura namibiensis (DSM 6313), its use for the treatment of bacterial infections, viral infections and/or pain, and pharmaceutical composition comprising it.
    Type: Application
    Filed: April 2, 2009
    Publication date: December 3, 2009
    Applicant: sanofi-aventis
    Inventors: Gerhard Seibert, László Vértesy, Joachim Wink, Irvin Winkler, Mark Broenstrup, Holger Hoffmann, Hans Guehring, Luigi Toti, Roderich Süssmuth, George M. Sheldrick, Kathrin Meindl
  • Patent number: 6794170
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is (a) encoded by the sequence specified in SEQ ID NO: 1 or a sequence derived therefrom on the basis of the degeneracy of the genetic code, or is (b) encoded by a nucleic acid sequence which codes for a functional fragment of (a) or (c) by a sequence which hybridizes with (a) or (b) under standard conditions, or is (d) encoded by a sequence which has more than 30% identity or more than 60% similarity with the sequence specified under (a).
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: September 21, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothée Heckmann, Wolfgang Wohlleben
  • Patent number: 6660835
    Abstract: The present invention relates to peptides, which are useful in treating Staphylococcus infections. More particularly, the inventive peptides interfere with the regulation of the agr system of Staphylococcus species, especially S. aureus, and thereby block the formation of different virulence factors. The inventive peptides comprise at least the amino acid sequence S V X A S Y F, whereby cyclic structures of that kind of peptides are the most potent blocking reagents.
    Type: Grant
    Filed: December 24, 1998
    Date of Patent: December 9, 2003
    Inventors: Michael Otto, Roderich Suessmuth, Guenther Jung, Friedrich Goetz
  • Publication number: 20030096335
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is
    Type: Application
    Filed: April 5, 2002
    Publication date: May 22, 2003
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothee Heckmann, Wolfgang Wohlleben
  • Patent number: 6566110
    Abstract: The invention relates to a process halogenation, which comprises halogenating a chemical compound in the presence of a halogenase, where the halogenase is (a) encoded by the sequence specified in SEQ ID NO: 1 or a sequence derived therefrom on the basis of the degeneracy of the genetic code, or is (b) encoded by a nucleic acid sequence which codes for a functional fragment of (a) or (c) by a sequence which hybridizes with (a) or (b) under standard conditions, or is (d) encoded by a sequence which has more than 30% identity or more than 60% similarity with the sequence specified under (a).
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: May 20, 2003
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Pelzer, Petra Huber, Roderich Suessmuth, Juergen Recktenwald, Dorothee Heckmann, Wolfgang Wohlleben